lowest dose semaglutide GLP-1s: What you need to know about weight loss drugs US FDA says lowest dose

Unraveling adipose tissue dysfunction: molecular Mechanisms, novel Biomarkers, and therapeutic targets for liver fat deposition

Obesity Coverage: A Divided Perspective Obesity affects over 40% of adults in the United States and has been recognized as a chronic disease by the American Medical Association since 2013

Reduced preference

[^1^]: source: "Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 19902016: a systematic analysis for the Global Burden of Disease Study 2016", The Lancet [^2^]: source: "Transforming healthcare with AI: The impact on the workforce and organizations", Nature Medicine [^3^]: source: "Artificial intelligence in healthcare: Anticipating challenges and opportunities", BMJ [^4^]: source: "The impact of artificial intelligence - Widespread job losses", The Economist) [^5^]: source: "Artificial Intelligence in Health Care: Anticipating Challenges to Ethics, Privacy, and Bias", Pennsylvania Bioethics Journal [^6^]: source: "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes", The New England Journal of Medicine [^7^]: source: "Artificial intelligence and diabetes management: a systematic review and meta-analysis", Journal of Diabetes Science and Technology [^8^]: source: "The Role of Prompt Engineering in Healthcare", Journal of Behavioral Medicine [^9^]: source: "AI and Personalized Messaging in Healthcare", Journal of Medical Systems [^10^]: source: "Ethical Considerations in Prompt Engineering", Journal of Medical Ethics [^11^]: source: "AI-Generated Prompts and Medication Adherence", Journal of Diabetes Science and Technology